Literature DB >> 16670175

Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy.

Eduardo E Benarroch1, Ann M Schmeichel, Paola Sandroni, Phillip A Low, Joseph E Parisi.   

Abstract

We sought to determine whether there is differential involvement of different groups of hypothalamic arginine-vasopressin (AVP) synthesizing neurons in multiple system atrophy (MSA). Hypothalamus was obtained from five subjects with clinical diagnosis of MSA confirmed neuropathologically and five age-matched controls. Sections were immunostained for AVP, and cells with visible nuclei were counted in the posterior portion of the paraventricular nucleus (PVNp), supraoptic nucleus (SON), magnocellular PVN and suprachiasmatic nucleus (SCN). Sections of the hypothalamus and medulla were also immunostained for tyrosine hydroxylase (TH). There was a significant loss of AVP neurons in the PVNp in MSA compared with controls (17 +/- 3 versus 59 +/- 10 cells/section, P < 0.01). There was preservation of AVP- and TH-immunoreactive neurons in the SON and magnocellular PVN in all MSA cases. In contrast, there was marked depletion of TH-immunoreactive fibres innervating these magnocellular AVP neurons, coincident with a loss of neurons in the A1 area (6 +/- 1 versus 13 +/- 1 cells/section, P < 0.01). There was loss of AVP neurons in the SCN in MSA compared with control cases (14 +/- 3 versus 71 +/- 16 cells/section, P < 0.02). Our results indicate that, in MSA, loss of AVP neurons in the PVNp may contribute to sympathetic failure, whereas loss of catecholaminergic input from the brainstem to the magnocellular AVP neurons may contribute to impaired AVP secretion in response to orthostatic stress. Loss of AVP neurons in the SCN may contribute to impaired circadian regulation of endocrine and autonomic functions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670175     DOI: 10.1093/brain/awl109

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  17 in total

1.  Orthostatic hypotension is differentially associated with the cerebellar versus the parkinsonian variant of multiple system atrophy: a comparative study.

Authors:  Gregor Karl Wenning; Roberta Granata; Florian Krismer; Susanne Dürr; Klaus Seppi; Werner Poewe; Katharine Bleasdale-Barr; Christopher J Mathias
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

2.  Sleep Disorders in Atypical Parkinsonism.

Authors:  Sabra M Abbott; Aleksandar Videnovic
Journal:  Mov Disord Clin Pract       Date:  2014-06-01

3.  Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial.

Authors:  Phillip A Low; David Robertson; Sid Gilman; Horacio Kaufmann; Wolfgang Singer; Italo Biaggioni; Roy Freeman; Susan Perlman; Robert A Hauser; William Cheshire; Stephanie Lessig; Steven Vernino; Jay Mandrekar; William D Dupont; Thomas Chelimsky; Wendy R Galpern
Journal:  Lancet Neurol       Date:  2014-02-05       Impact factor: 44.182

4.  Multiple system atrophy: a disorder targeting the brainstem control of survival.

Authors:  Eduardo E Benarroch
Journal:  Clin Auton Res       Date:  2019-10-24       Impact factor: 4.435

Review 5.  Does the Type of Multisystem Atrophy, Parkinsonism, or Cerebellar Ataxia Impact on the Nature of Sleep Disorders?

Authors:  Luigi Ferini-Strambi; Sara Marelli; Romina Combi
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

6.  Leptin upregulation in advanced multiple system atrophy with hypocholesterolemia and unexpected fat accumulation.

Authors:  Utako Nagaoka; Toshio Shimizu; Toshiki Uchihara
Journal:  Neurol Sci       Date:  2015-03-26       Impact factor: 3.307

Review 7.  Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

Authors:  Nathan P Staff; David T Jones; Wolfgang Singer
Journal:  Mayo Clin Proc       Date:  2019-05       Impact factor: 7.616

8.  Loss of A5 noradrenergic neurons in multiple system atrophy.

Authors:  Eduardo E Benarroch; Ann M Schmeichel; Phillip A Low; Paola Sandroni; Joseph E Parisi
Journal:  Acta Neuropathol       Date:  2008-02-23       Impact factor: 17.088

9.  Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.

Authors:  Axel Lipp; Paola Sandroni; J Eric Ahlskog; Robert D Fealey; Kurt Kimpinski; Valeria Iodice; Tonette L Gehrking; Stephen D Weigand; David M Sletten; Jade A Gehrking; Kim K Nickander; Wolfgang Singer; Demetrius M Maraganore; Sid Gilman; Gregor K Wenning; Clifford W Shults; Phillip A Low
Journal:  Arch Neurol       Date:  2009-06

10.  A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.

Authors:  Eduardo De Pablo-Fernández; Robert Courtney; Thomas T Warner; Janice L Holton
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.